Insider filing · PLSE

Robert W Duggan bought $2.8M of Pulse Biosciences (PLSE)

Executed Sep 11 2024, disclosed Sep 13 2025, 366 days later, against a two-business-day limit.

Over the 21 trading sessions from the disclosed entry session (Sep 12 2025), the stock returned +17.3% (delay-adjusted); from the execution session (Sep 11 2024), -8.3%. Derived: entry at the session's open, exit at the close 20 sessions later.

RD Robert W Duggan Director profile →

Robert W Duggan (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in PLSE. Across 4 priced purchase filings, the average 21-session return was +10.9% from execution and +11.5% from disclosure (delay-adjusted; derived). The largest single filing was $50.0M of SMMT (3,810,000 sh × $13.12, as filed), executed Jun 12.

PLSE PLSE PLSE · 15 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→